Similarly, diminished expression of E-cadherin following thapsigargin treatment was restored following PP2 treatment further providing evidence that SRC kinase inhibitor, PP2 can be of potential use to block ER stress and EMT in lung adenocarcinoma cells (Figure 8). The gene discussed is CDH1; the disease is lung adenocarcinoma.